The Balearic Islands Government Council authorizes the contracting of the supply of the biosimilar medicine somatropin for hospitals dependent on the Health Service for an estimated value of 1,5 million euros. This contract is expected to be valid until December 31, 2024.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
